- Home
- ATOS vs FGC Comparison
ATOS vs FGC Comparison
Compare ATOS & FGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATOS | FGC |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9M | 22.5M |
| IPO Year | 2010 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ATOS | FGC |
|---|---|---|
| Price | $2.07 | $6.20 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 73.9K | 51.6K |
| Earning Date | 11-10-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,758.00 | ★ $32,023,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 20.70 |
| 52 Week Low | $0.53 | $4.65 |
| 52 Week High | $7.56 | $7.78 |
Technical Indicators
Market Signals| Indicator | ATOS | FGC |
|---|---|---|
| Relative Strength Index (RSI) | 39.61 | 51.88 |
| Support Level | $1.76 | $5.74 |
| Resistance Level | $2.60 | $6.49 |
| Average True Range (ATR) | 0.18 | 0.66 |
| MACD | -0.04 | 0.08 |
| Stochastic Oscillator | 7.47 | 70.64 |
Price Performance
Historical ComparisonAbout ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
About FGC FG Communities Holdings Inc. Common Stock
FG Communities Holdings Inc, formerly FG Nexus Inc operates through two primary segments: Digital Assets and Merchant Banking, with Digital Assets contributing the majority of revenue. The Company functions as a digital asset treasury, mainly holding Ethereum (ETH) and exploring opportunities in the tokenization of real-world assets, leveraging ETH as the foundation for digital finance, stablecoins, DeFi, and tokenized assets. The Merchant Banking segment offers strategic, administrative, and regulatory support to newly formed SPACs through the Company's SPAC platform.